Going through some old posts on my (seemingly defunct) personal blog for street cred on the topic, I was reminded how much I really liked Twitter lists and niches, as I’ve been rekindling that old flame lately. What I’m enjoying about Twitter lists these days is how far they’ve come toward serving as an all [...]

Three events in early June spotlighted the pace of change in how new treatments are being created.  The biggest winners from new approaches to drug development will be patients, who hold all the keys to how new treatments are found and tested.  The clearest losers will be policymakers, who will face more worries about meeting [...]